Miscellaneous ocular agents:

Indications for OZURDEX:

Macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Non-infectious uveitis affecting the posterior segment of the eye. Diabetic macular edema.


For ophthalmic intravitreal injection only. One implant in each affected eye(s).


Not established.


Ocular or periocular infections. Glaucoma (cup to disc ratio >0.8). Torn or ruptured posterior lens capsule.


Monitor for intravitreal injection-related effects (eg, endophthalmitis, eye inflammation, increased intraocular pressure, retinal detachments) following the injection. Risk of potential steroid-related effects (eg, posterior subcapsular cataracts, glaucoma, secondary ocular infections). History of ocular herpes simplex: not recommended. Risk of implant migration to anterior chamber if posterior lens capsule is not intact. Pregnancy. Nursing mothers.

Pharmacologic Class:


Adverse Reactions:

Increased intraocular pressure, conjunctival hemorrhage, eye pain, conjunctival hyperemia, ocular hypertension, cataracts.

How Supplied:

Single-use intravitreal implant—1 (w. applicator)

Pricing for OZURDEX

0.7mg implant (Qty: 1)
Appx. price $1369